/

Kailera Therapeutics

Developing clinical-stage injectable and oral therapies for obesity.

BiotechnologyPharmaceuticals kailera.com ↗

Company facts

Founded: 2024
Employees: 144
Headquarters: United States
Type: Private
Funding: Series B · $600M · 2025